Engineering the oxidative myocardium: ROS-responsive biomaterials for precision cardiovascular delivery in ischemia-reperfusion injury and post-infarction remodeling
Hossein Omidian, Kwadwo A. Mfoafo, Luigi X. Cubeddu · 2026
Read Engineering the oxidative myocardium: ROS-responsive biomaterials for precision cardiovascular delivery in ischemia-reperfusion injury and post-infarction remodeling by Hossein Omidian, Kwadwo A. Mfoafo, Luigi X. Cubeddu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13623321.txt.
Description
Omidian, Mfoafo, and Cubeddu review smart materials that release heart drugs only where harmful oxygen byproducts build up. After a heart attack, restored blood flow can itself injure the muscle, and later scarring reshapes the heart. Their 2026 review weighs lab-stage designs that sense that oxidative stress and answer with drug release, cleanup of the harmful species, or both.
Four broad families are compared: gels injected into the heart, tiny particles sent through the blood, nanozymes that keep mopping up the harmful species, and systems based on cells, genes, or gases. Each has a clear drawback, from invasive delivery to weak safety data. The authors note that no design has yet proven itself in patients. They call for shared definitions, large-animal tests, and better safety tracking.
Catalog record
| CREATOR | Hossein Omidian, Kwadwo A. Mfoafo, Luigi X. Cubeddu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 91 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |